Summary of clinical data, histology, and PMSA mRNA protein in patient's population
| Variable categories | Frequency (n = 130) | % (of nonmissing) | ||
|---|---|---|---|---|
| Diagnosis | ||||
| Endometrioid | 103 | 79 | ||
| Serous and mixed | 18 | 14 | ||
| Other | 9 | 7 | ||
| Grade | ||||
| 1 | 51 | 39 | ||
| 2 | 46 | 35 | ||
| 3 | 33 | 25 | ||
| Stage | ||||
| I | 83 | 64 | ||
| II | 21 | 16 | ||
| III | 17 | 13 | ||
| IV | 9 | 7 | ||
| mRNA | ||||
| ≤0.5 | 15 | 31 | ||
| >0.5 | 34 | 69 | ||
| Immunohistochemistry percent | ||||
| Negative | 52 | 40 | ||
| Positive | 78 | 60 | ||
| Immunohistochemistry intensity | ||||
| None/weak | 88 | 68 | ||
| Moderate/strong | 42 | 32 | ||
| Immunohistochemistry pattern | ||||
| None | 45 | 35 | ||
| C | 47 | 36 | ||
| A or A/C | 38 | 29 | ||
| Recurrence status | ||||
| Persistent | 6 | 8 | ||
| Recurrence | 17 | 23 | ||
| None | 50 | 68 | ||
| Status | ||||
| AWD | 3 | 4 | ||
| ANED | 44 | 63 | ||
| DOD | 18 | 26 | ||
| DNED | 5 | 7 | ||
| Age at surgery (y), median (range) | 66 (30-87) | |||
| Follow-up time (mo), median (range) | 17 (0-90) | |||